Product sales and royalty revenue of $7.0 million up 118% from Q3 2022, representing the eleventh straight quarter of sequential product sales and royalty revenue growth Generated $0.9 million in positive cash flow from operations; ended quarter with $22.1 …
The combination of imdusiran and VTP-300 provides a meaningful reduction of HBsAg levels that are maintained well below baseline Preliminary data in subset of patients given imdusiran and then VTP-300 show early signs of immune activation WARMINSTER, Pa. …
Reported updated data from ongoing Phase 1b trial further supporting the potential of tegoprubart as a novel kidney transplant immunosuppressive therapy to prevent rejection and better preserve organ function First participant dosed in Phase 2 BESTOW trial …
Demonstrated initial clinical validation of tumor-selective activation technology for both XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4, and XTX202, a tumor-activated, beta-gamma IL-2 On track to activate trial sites for XTX101 dose escalation in …
- Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue - - Q3 Adjusted EBITDA Improved Year-Over-Year to $(2.6) Million Compared to $(3.7) …
CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jason Trevisan, Chief Executive Officer, is scheduled …
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for …
NEW YORK, Nov. 09, 2023 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today provided a corporate update and financial results for the …
The Future of Medicine Art Contest (FoMAC) is excited to present its winner with a cash award of $1,000 on Saturday, November 18 at 6:30pm. SHERWOOD PARK, AB, CANADA, November 9, 2023 /EINPresswire.com/ -- Following its highly successful spring contest …
Completed dose escalation in Phase 1 Trial of INB-100 with updated clinical data to be presented at the American Society of Hematology (ASH) Annual Meeting on December 11, 2023 (Abstract Number: 4853). Held Research & Development Day, featuring Leo …
Tuspetinib (TUS) Targets Venetoclax (VEN) Resistance Mechanisms TUS/VEN Combination Therapy Active in R/R VEN Failure AML Patients – Guides Toward Accelerated Approval Path, Including FLT3 Mutated and Wildtype TUS/VEN Overall Response Rate of 48% in …
Board of Directors increases share repurchase program authorization from $22 million to $40 million. Company expects to achieve full Build America, Buy America (BABA) Act compliance by end of calendar 2024. MINNEAPOLIS, Nov. 09, 2023 (GLOBE NEWSWIRE) -- …
SEATTLE and VANCOUVER, British Columbia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and …
New York, NY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Le Vian, the world’s leading luxury jewelry brand, has partnered with Jared, the leader in accessible luxury and premium luxury banner within Signet Jewelers, to launch an exclusive and original collection of …
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated patient dosing. Ended the third quarter of 2023 with $105.6 …
Company is on track with ongoing repeat-dose study under allergen-induced allergic rhinitis conditions requested by U.S. FDA with topline data expected in Q1 2024 Resubmission of New Drug Application (NDA) for neffy® anticipated in H1 2024 Ended third …
SALT LAKE CITY, Nov. 09, 2023 (GLOBE NEWSWIRE) -- --OMNIQ Corp. (NASDAQ: OMQS) a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, will release Third Quarter 2023 Earnings after the market close on Monday, November 13th, 2023. The …
Commonwealth of Virginia Office of the Attorney General Jason S. Miyares Attorney General 202 North 9th Street Richmond, Virginia 23219 804-786-2071 FAX 804-786-1991 Virginia Relay Service 800-828-1120 For media inquiries only, contact: Victoria …
HostingAdvice survey reports millennials lead the majority of the 36% who trust ChatGPT to keep their information safe. GAINESVILLE, FLORIDA, UNITED STATES, November 9, 2023 /EINPresswire.com/ -- By and large, Americans view generative AI as a helpful …
(Subscription required) During oral arguments, justices appeared uneasy with the idea of barring trial courts from striking unwieldy claims brought under the Private Attorneys General Act.
07 days 13:53:11
